Diabetes and Breast Cancer Subtypes

Show full item record



Permalink

http://hdl.handle.net/10138/175469

Citation

Bronsveld , H K , Jensen , V , Vahl , P , De Bruin , M L , Cornelissen , S , Sanders , J , Auvinen , A , Haukka , J , Andersee , M , Vestergaard , P & Schmidt , M K 2017 , ' Diabetes and Breast Cancer Subtypes ' , PLoS One , vol. 12 , no. 1 , 0170084 . https://doi.org/10.1371/journal.pone.0170084

Title: Diabetes and Breast Cancer Subtypes
Author: Bronsveld, Heleen K.; Jensen, Vibeke; Vahl, Pernille; De Bruin, Marie L.; Cornelissen, Sten; Sanders, Joyce; Auvinen, Anssi; Haukka, Jari; Andersee, Morten; Vestergaard, Peter; Schmidt, Marjanka K.
Contributor: University of Helsinki, Clinicum
Date: 2017-01-11
Language: eng
Number of pages: 16
Belongs to series: PLoS One
ISSN: 1932-6203
URI: http://hdl.handle.net/10138/175469
Abstract: Background Women with diabetes have a worse survival after breast cancer diagnosis compared to women without diabetes. This may be due to a different etiological profile, leading to the development of more aggressive breast cancer subtypes. Our aim was to investigate whether insulin and non-insulin treated women with diabetes develop specific clinicopathological breast cancer subtypes compared to women without diabetes. Methods and Findings This cross-sectional study included randomly selected patients with invasive breast cancer diagnosed in 2000-2010. Stratified by age at breast cancer diagnosis (50 years), women with diabetes were 2:1 frequency-matched on year of birth and age at breast cancer diagnosis (both in 10-year categories) to women without diabetes, to select similar to 300 patients with tumor tissue available. Tumor MicroArrays were stained by immunohistochemistry for estrogen and progesterone receptor (ER, PR), HER2, Ki67, CK5/6, CK14, and p63. A pathologist scored all stains and revised morphology and grade. Associations between diabetes/insulin treatment and clinicopathological subtypes were analyzed using multivariable logistic regression. Morphology and grade were not significantly different between women with diabetes (n = 211) and women without diabetes (n = 101), irrespective of menopausal status. Premenopausal women with diabetes tended to have more often PR-negative (OR = 2.44(95%C1:1.07-5.55)), HER2-negative (OR = 2.84(95%C1:1.11-7.22)), and basal-like (OR = 3.14(95%C1:1.03-9.60) tumors than the women without diabetes, with non-significantly increased frequencies of ER-negative (OR = 2.48(95`)/X1:0.95-6.45)) and triple negative (OR = 2.60(95%CI:0.88-7.67) tumors. After adjustment for age and BMI, the associations remained similar in size but less significant. We observed no evidence for associations of clinicopathological subtypes with diabetes in postmenopausal women, or with insulin treatment in general. Conclusions We found no compelling evidence that women with diabetes, treated with or without insulin, develop different breast cancer subtypes than women without diabetes. However, premenopausal women with diabetes tended to develop breast tumors that do not express hormonal receptors, which are typically associated with poor prognosis.
Subject: POPULATION-BASED COHORT
BODY-MASS INDEX
GENE-EXPRESSION
MELLITUS
INSULIN
RISK
MORTALITY
ASSOCIATION
METAANALYSIS
OUTCOMES
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Diabetes_and_Breast_Cancer_Subtypes.pdf 1014.Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record